{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:31:56Z","timestamp":1781505116575,"version":"3.54.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Science and Technology Research Fund of Guangdong province","award":["A2023263"],"award-info":[{"award-number":["A2023263"]}]},{"name":"Leading Talent in Science and Technology Innovation of Zhongshan","award":["LJ2021004"],"award-info":[{"award-number":["LJ2021004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To determine whether a reduced dose of follicle-stimulating hormone (FSH) before human chorionic gonadotropin (hCG) trigger during ovarian stimulation can affect in vitro fertilization (IVF) outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included 347 patients with a normal ovarian response who received a reduced dose of FSH before hCG trigger for 2\u20133 days (Group A) and 671 patients who did not receive a reduced dose (Group B) from a university-affiliated IVF center between January 2021 and December 2022. The primary endpoint was estrogen (E2) and progesterone (P) levels on the day of hCG trigger, fresh embryo transfer cycles, laboratory outcomes, and clinical outcomes between the two groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>On the day of hCG trigger, Group A had significantly lower E2 and P levels than those in Group B (3454.95\u2009\u00b1\u20091708.14 pg\/mL versus 3798.70\u2009\u00b1\u20091774.26 pg\/mL, p\u2009=\u20090.003; and 1.23\u2009\u00b1\u20090.53 ng\/mL versus 1.37\u2009\u00b1\u20090.59 ng\/mL, p\u2009&lt;\u20090.001, respectively). The proportion of patients with P levels\u2009\u2265\u20091.5 ng\/mL was 22.48% in Group A compared to 34.58% in Group B (p\u2009&lt;\u20090.001), while the proportion of patients with E2\u2009\u2265\u20095000 pg\/mL was 15.27% in Group A compared to 25.93% in Group B (p\u2009&lt;\u20090.001). The fresh embryo-transfer cycle rate in Group A was higher than that in group B (54.47% and 32.64%, respectively; p\u2009&lt;\u20090.001). Despite the reduction in FSH dosage, there were no significant differences between groups regarding the number of oocytes retrieved, total number of mature oocytes, normal fertilization rate, cleavage rate, Day 3 top-quality rate, implantation rate, pregnancy rate per cycle, and early pregnancy loss rate.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>While a reduced dose of FSH prior to hCG trigger during ovarian stimulation did not significantly affect IVF outcomes, it was associated with lower E2 and P levels, resulting in fewer cycles with E2\u2009\u2265\u20095000 pg\/mL and P\u2009\u2265\u20091.5 ng\/mL on the day of the hCG trigger.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-023-05943-5","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T04:01:53Z","timestamp":1692936113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhanhui","family":"Ou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nengqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"issue":"10","key":"5943_CR1","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1093\/humrep\/der251","volume":"26","author":"P Devroey","year":"2011","unstructured":"Devroey P, Polyzos NP, Blockeel C. An OHSS-Free clinic by segmentation of IVF treatment. Hum Reprod. 2011;26(10):2593\u20137.","journal-title":"Hum Reprod"},{"issue":"6","key":"5943_CR2","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.fertnstert.2011.01.163","volume":"95","author":"G Griesinger","year":"2011","unstructured":"Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a freeze-all strategy: a prospective multicentric study. Fertil Steril. 2011;95(6):2029. 33 e1.","journal-title":"Fertil Steril"},{"issue":"3","key":"5943_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0015-0282(97)80080-5","volume":"67","author":"F Ubaldi","year":"1997","unstructured":"Ubaldi F, Bourgain C, Tournaye H, Smitz J, Van Steirteghem A, Devroey P. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 1997;67(3):521\u20136.","journal-title":"Fertil Steril"},{"issue":"5","key":"5943_CR4","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/S0015-0282(02)03323-X","volume":"78","author":"E Kolibianakis","year":"2002","unstructured":"Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, et al. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002;78(5):1025\u20139.","journal-title":"Fertil Steril"},{"issue":"2","key":"5943_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.fertnstert.2011.05.050","volume":"96","author":"BS Shapiro","year":"2011","unstructured":"Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil Steril. 2011;96(2):344\u20138.","journal-title":"Fertil Steril"},{"issue":"6","key":"5943_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1513873","volume":"375","author":"ZJ Chen","year":"2016","unstructured":"Chen ZJ, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016;375(6):523\u201333.","journal-title":"N Engl J Med"},{"issue":"1","key":"5943_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.fertnstert.2013.09.025","volume":"101","author":"O Ishihara","year":"2014","unstructured":"Ishihara O, Araki R, Kuwahara A, Itakura A, Saito H, Adamson GD. Impact of frozen-thawed single-blastocyst transfer on maternal and neonatal outcome: an analysis of 277,042 single-embryo transfer cycles from 2008 to 2010 in Japan. Fertil Steril. 2014;101(1):128\u201333.","journal-title":"Fertil Steril"},{"issue":"5","key":"5943_CR8","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/humrep\/des036","volume":"27","author":"A Sazonova","year":"2012","unstructured":"Sazonova A, Kallen K, Thurin-Kjellberg A, Wennerholm UB, Bergh C. Obstetric outcome in singletons after in vitro fertilization with cryopreserved\/thawed embryos. Hum Reprod. 2012;27(5):1343\u201350.","journal-title":"Hum Reprod"},{"issue":"3","key":"5943_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humrep\/det440","volume":"29","author":"A Pinborg","year":"2014","unstructured":"Pinborg A, Henningsen AA, Loft A, Malchau SS, Forman J, Andersen AN. Large baby syndrome in singletons born after frozen embryo transfer (FET): is it due to maternal factors or the cryotechnique? Hum Reprod. 2014;29(3):618\u201327.","journal-title":"Hum Reprod"},{"issue":"6","key":"5943_CR10","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.fertnstert.2003.07.002","volume":"80","author":"E Bosch","year":"2003","unstructured":"Bosch E, Valencia I, Escudero E, Crespo J, Simon C, Remohi J, et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril. 2003;80(6):1444\u20139.","journal-title":"Fertil Steril"},{"issue":"5","key":"5943_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/humupd\/dmt014","volume":"19","author":"CA Venetis","year":"2013","unstructured":"Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update. 2013;19(5):433\u201357.","journal-title":"Hum Reprod Update"},{"issue":"8","key":"5943_CR12","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1093\/humrep\/deq125","volume":"25","author":"E Bosch","year":"2010","unstructured":"Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Jenkins J, et al. Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum Reprod. 2010;25(8):2092\u2013100.","journal-title":"Hum Reprod"},{"issue":"7","key":"5943_CR13","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/humrep\/der126","volume":"26","author":"E Labarta","year":"2011","unstructured":"Labarta E, Martinez-Conejero JA, Alama P, Horcajadas JA, Pellicer A, Simon C, et al. Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011;26(7):1813\u201325.","journal-title":"Hum Reprod"},{"issue":"2","key":"5943_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.fertnstert.2017.05.007","volume":"108","author":"A Wang","year":"2017","unstructured":"Wang A, Santistevan A, Hunter Cohn K, Copperman A, Nulsen J, Miller BT, et al. Freeze-only versus fresh embryo transfer in a multicenter matched cohort study: contribution of progesterone and maternal age to success rates. Fertil Steril. 2017;108(2):254\u201361. e4.","journal-title":"Fertil Steril"},{"issue":"3","key":"5943_CR15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.rbmo.2010.11.002","volume":"22","author":"I Van Vaerenbergh","year":"2011","unstructured":"Van Vaerenbergh I, Fatemi HM, Blockeel C, Van Lommel L, In\u2019t Veld P, Schuit F, et al. Progesterone rise on HCG day in GnRH antagonist\/rFSH stimulated cycles affects endometrial gene expression. Reprod Biomed Online. 2011;22(3):263\u201371.","journal-title":"Reprod Biomed Online"},{"issue":"6","key":"5943_CR16","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/humrep\/deg208","volume":"18","author":"M Aboulghar","year":"2003","unstructured":"Aboulghar M. Prediction of ovarian hyperstimulation syndrome (OHSS). Estradiol level has an important role in the prediction of OHSS. Hum Reprod. 2003;18(6):1140\u20131.","journal-title":"Hum Reprod"},{"issue":"2","key":"5943_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ejogrb.2012.02.025","volume":"162","author":"D Kyrou","year":"2012","unstructured":"Kyrou D, Al-Azemi M, Papanikolaou EG, Donoso P, Tziomalos K, Devroey P, et al. The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist\/recombinant FSH-stimulated cycles. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):165\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"5943_CR18","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/humrep\/dex010","volume":"32","author":"O Oktem","year":"2017","unstructured":"Oktem O, Akin N, Bildik G, Yakin K, Alper E, Balaban B, et al. FSH Stimulation promotes progesterone synthesis and output from human granulosa cells without luteinization. Hum Reprod. 2017;32(3):643\u201352.","journal-title":"Hum Reprod"},{"issue":"11","key":"5943_CR19","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1093\/humrep\/dew213","volume":"31","author":"B Lawrenz","year":"2016","unstructured":"Lawrenz B, Beligotti F, Engelmann N, Gates D, Fatemi HM. Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles. Hum Reprod. 2016;31(11):2554\u201360.","journal-title":"Hum Reprod"},{"issue":"11","key":"5943_CR20","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1007\/s10815-017-1010-7","volume":"34","author":"Y Prapas","year":"2017","unstructured":"Prapas Y, Ravanos K, Petousis S, Panagiotidis Y, Papatheodorou A, Margioula-Siarkou C, et al. GnRH antagonist administered twice the day before hCG trigger combined with a step-down protocol may prevent OHSS in IVF\/ICSI antagonist cycles at risk for OHSS without affecting the reproductive outcomes: a prospective randomized control trial. J Assist Reprod Genet. 2017;34(11):1537\u201345.","journal-title":"J Assist Reprod Genet"},{"key":"5943_CR21","doi-asserted-by":"publisher","first-page":"661707","DOI":"10.3389\/fendo.2021.661707","volume":"12","author":"B Lawrenz","year":"2021","unstructured":"Lawrenz B, Coughlan C, Melado L, Digma S, Sibal J, Jean A, et al. Step-down of FSH- Dosage during Ovarian Stimulation - Basic Lessons to be learnt from a Randomized Controlled Trial. Front Endocrinol. 2021;12:661707.","journal-title":"Front Endocrinol"},{"issue":"3","key":"5943_CR22","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1093\/humrep\/deu362","volume":"30","author":"CA Venetis","year":"2015","unstructured":"Venetis CA, Kolibianakis EM, Bosdou JK, Lainas GT, Sfontouris IA, Tarlatzis BC, et al. Estimating the net effect of progesterone elevation on the day of hCG on live birth rates after IVF: a cohort analysis of 3296 IVF cycles. Hum Reprod. 2015;30(3):684\u201391.","journal-title":"Hum Reprod"},{"issue":"1","key":"5943_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.fertnstert.2015.09.008","volume":"105","author":"F Martinez","year":"2016","unstructured":"Martinez F, Rodriguez I, Devesa M, Buxaderas R, G\u00f3mez MJ, Coroleu B. Should progesterone on the human chorionic gonadotropin day still be measured? Fertil Steril. 2016;105(1):86\u201392.","journal-title":"Fertil Steril"},{"issue":"3","key":"5943_CR24","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.fertnstert.2005.02.053","volume":"84","author":"M Arslan","year":"2005","unstructured":"Arslan M, Bocca S, Mirkin S, Barroso G, Stadtmauer L, Oehninger S. Controlled ovarian hyperstimulation protocols for in vitro fertilization: two decades of experience after the birth of Elizabeth Carr. Fertil Steril. 2005;84(3):555\u201369.","journal-title":"Fertil Steril"},{"issue":"3","key":"5943_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.fertnstert.2007.06.080","volume":"90","author":"SN Koundouros","year":"2008","unstructured":"Koundouros SN. A comparison study of a novel stimulation protocol and the conventional low dose step-up and step-down regimens in patients with polycystic ovary syndrome undergoing in vitro fertilization. Fertil Steril. 2008;90(3):569\u201375.","journal-title":"Fertil Steril"},{"issue":"2","key":"5943_CR26","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","volume":"2020","author":"T Ovarian Stimulation","year":"2020","unstructured":"Ovarian Stimulation T, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI(dagger). Hum Reprod open. 2020;2020(2):hoaa009.","journal-title":"Hum Reprod open"},{"issue":"8","key":"5943_CR27","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1093\/humrep\/17.8.2009","volume":"17","author":"M Filicori","year":"2002","unstructured":"Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Spettoli D, Taraborrelli S, et al. Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration. Hum Reprod. 2002;17(8):2009\u201315.","journal-title":"Hum Reprod"},{"key":"5943_CR28","first-page":"6","volume":"2017","author":"A D\u2019Angelo","year":"2017","unstructured":"D\u2019Angelo A, Amso NN, Hassan R. Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database of Systematic Reviews. 2017;2017:6.","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"5943_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.rbmo.2014.04.014","volume":"29","author":"S Talebi Chahvar","year":"2014","unstructured":"Talebi Chahvar S, Zosmer A, Caragia A, Balestrini S, Sabatini L, Tranquilli AL, et al. Coasting, embryo development and outcomes of blastocyst transfer: a case-control study. Reprod Biomed Online. 2014;29(2):231\u20138.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"5943_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.fertnstert.2005.07.1335","volume":"85","author":"JA Garc\u00eda-Velasco","year":"2006","unstructured":"Garc\u00eda-Velasco JA, Isaza V, Quea G, Pellicer A. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing? Fertil Steril. 2006;85(3):547\u201354.","journal-title":"Fertil Steril"},{"issue":"3","key":"5943_CR31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s13318-015-0257-6","volume":"41","author":"M Wolzt","year":"2016","unstructured":"Wolzt M, Gouya G, Sator M, Hemetsberger T, Irps C, Rettenbacher M, et al. Comparison of pharmacokinetic and safety profiles between Bemfola(\u00ae) and Gonal-f(\u00ae) after subcutaneous application. Eur J Drug Metab Pharmacokinet. 2016;41(3):259\u201365.","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"5711","key":"5943_CR32","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/279336a0","volume":"279","author":"GF Erickson","year":"1979","unstructured":"Erickson GF, Wang C, Hsueh AJ. FSH induction of functional LH receptors in granulosa cells cultured in a chemically defined medium. Nature. 1979;279(5711):336\u20138.","journal-title":"Nature"},{"issue":"6","key":"5943_CR33","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","volume":"105","author":"G Poseidon","year":"2016","unstructured":"Poseidon G, Alviggi C, Andersen CY, Buehler K, Conforti A, De Placido G, et al. A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept. Fertil Steril. 2016;105(6):1452\u20133.","journal-title":"Fertil Steril"},{"issue":"12","key":"5943_CR34","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1093\/humrep\/der318","volume":"26","author":"AN Andersen","year":"2011","unstructured":"Andersen AN, Witjes H, Gordon K, Mannaerts B. Xpect i. predictive factors of ovarian response and clinical outcome after IVF\/ICSI following a rFSH\/GnRH antagonist protocol with or without oral contraceptive pre-treatment. Hum Reprod. 2011;26(12):3413\u201323.","journal-title":"Hum Reprod"},{"issue":"2","key":"5943_CR35","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.fertnstert.2013.04.024","volume":"100","author":"SL Broer","year":"2013","unstructured":"Broer SL, Dolleman M, van Disseldorp J, Broeze KA, Opmeer BC, Bossuyt PM, et al. Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertil Steril. 2013;100(2):420\u20139. e7.","journal-title":"Fertil Steril"},{"issue":"1","key":"5943_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10815-007-9187-9","volume":"25","author":"XM Zhen","year":"2008","unstructured":"Zhen XM, Qiao J, Li R, Wang LN, Liu P. The clinical analysis of poor ovarian response in in-vitro-fertilization embryo-transfer among chinese couples. J Assist Reprod Genet. 2008;25(1):17\u201322.","journal-title":"J Assist Reprod Genet"},{"issue":"3","key":"5943_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3109\/19396368.2015.1033779","volume":"61","author":"PF Li","year":"2015","unstructured":"Li PF, Zhu H, Tan L, Zhao DM, Ma LY, Xiang YG, et al. Effects of high progesterone on outcomes of in vitro fertilization-embryo transfer in patients with different ovarian responses. Syst Biology Reproductive Med. 2015;61(3):161\u20137.","journal-title":"Syst Biology Reproductive Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05943-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-023-05943-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-023-05943-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T22:05:22Z","timestamp":1700345122000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-023-05943-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5943"],"URL":"https:\/\/doi.org\/10.1186\/s12884-023-05943-5","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"assertion":[{"value":"22 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations.This study was approved by the Ethics Committee of Zhongshan Boai Hospital (KY-2023-04-02).Informed consent was obtained from the enrolled patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"612"}}